Home/Filings/4/0001618835-17-000001
4//SEC Filing

Neothetics, Inc. 4

Accession 0001618835-17-000001

$EVFMCIK 0001618835operating

Filed

Mar 5, 7:00 PM ET

Accepted

Mar 6, 3:47 PM ET

Size

5.3 KB

Accession

0001618835-17-000001

Insider Transaction Report

Form 4
Period: 2017-03-02
Knudson Susan A.
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-03-02+100,000100,000 total
    Exercise: $1.43Exp: 2027-03-02Common Stock (100,000 underlying)
Footnotes (1)
  • [F1](i) One half of the option shares vest upon receipt and completed analysis of LIPO-202 CL-31 trial data and (ii) the remaining one half of the option shares vest at the earlier of (a) 12/31/2017 or (b) upon the event of a change in control.

Issuer

Neothetics, Inc.

CIK 0001618835

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001618835

Filing Metadata

Form type
4
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 3:47 PM ET
Size
5.3 KB